All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants-Case Series and Systematic Review of Reported Cases

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F15%3A00064387" target="_blank" >RIV/00159816:_____/15:00064387 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.07.021" target="_blank" >http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.07.021</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.07.021" target="_blank" >10.1016/j.jstrokecerebrovasdis.2015.07.021</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants-Case Series and Systematic Review of Reported Cases

  • Original language description

    Background: Current guidelines do not recommend the administration of intravenous tissue plasminogen activator (IV-tPA) to patients with acute ischemic stroke (AIS) who take new oral anticoagulants (NOACs). We present a multicenter case series of IV-tPAuse while the patients are on NOACs, as well as a systematic review of the literature. Methods: We reviewed the medical records of consecutive patients on NOACs who received IV-tPA for symptoms of AIS at four participating stroke centers in the United States and Europe. Safety endpoints were post-thrombolysis symptomatic intracranial hemorrhage (sICH) or other serious systemic bleeding. Results: Between October 2010 and October 2014, 6 patients received IV-tPA for possible AIS while taking dabigatran. None of the patients had sICH or any other hemorrhagic complication. Literature review resulted in a total of 26 patients receiving IV-tPA while on NOACs (dabigatran: 15, rivaroxaban: 10, apixaban: 1). Among them, two patients experienced

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: St. Anne´s University Hospital Brno - International Clinical Research Center (FNUSA-ICRC)</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Stroke &amp; Cerebrovascular Diseases

  • ISSN

    1052-3057

  • e-ISSN

  • Volume of the periodical

    24

  • Issue of the periodical within the volume

    12

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    9

  • Pages from-to

    2685-2693

  • UT code for WoS article

    000367388800007

  • EID of the result in the Scopus database